← Leaderboards
Yifan Zhang
Princeton University
$153,308
Attributed
$153,308
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51.8K · FY2020–22$100K$75K$50K$25K$0
'20
'21
'22
Funding mix
By agency
NIH$153,308 · 1
By mechanism
F30$153,308 · 1
Top collaborators
No co-investigators on record.
Most similar at Princeton University
Same institution · by research overlap
- Mohammad R Seyedsayamdost$8,154,584
- Sampriti Mukherjee$2,443,025
- Bonnie L Bassler$14,097,173
- Mark P Brynildsen$3,947,068
- Bonnie Bassler$4,927,579
Others in their field
Other Emerging Leaders on “Animal Model”
- Ted Ross · University Of Georgia$71,962,304
- Leonard Freedman · Leidos Biomedical Research, Inc.$64,938,611
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$45,644,409
- Steven A. Ackerman · University Of Wisconsin-Madison$38,898,438
- Gary Fanger · Rise Therapeutics, Llc$16,982,327
Research focus
Animal ModelAnti-Bacterial AgentsAntibioticsAntibiotic TherapyAntimicrobialBactericideBiochemicalBiosynthetic ProteinsBurkholderiaBurkholderia PseudomalleiClinical MedicineClinical PracticeCollectionCombination Drug TherapyCombined Modality TherapyDihydrofolate ReductaseDosageDoseDrug CombinationsDrug TargetingEnzyme InhibitionEnzyme MechanismEnzymesAdverse Effects
Grant awards (4)
Using new modalities of synthetic-lethal interactions to find alternative antibacterial drug targets$51,752
F30 · FY2022 · GM · contact PI
Using new modalities of synthetic-lethal interactions to find alternative antibacterial drug targets$25,518
F30 · FY2021 · GM · contact PI
Using new modalities of synthetic-lethal interactions to find alternative antibacterial drug targets$25,518
F30 · FY2021 · GM · contact PI
Using new modalities of synthetic-lethal interactions to find alternative antibacterial drug targets$50,520
F30 · FY2020 · GM · contact PI